Cargando…

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential

The coronavirus disease 2019 (COVID‐19) pandemic has become a serious burden on global public health. Although therapeutic drugs against COVID‐19 have been used in many countries, their efficacy is still limited. We here reported nanobody (Nb) phage display libraries derived from four camels immuniz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gai, Junwei, Ma, Linlin, Li, Guanghui, Zhu, Min, Qiao, Peng, Li, Xiaofei, Zhang, Haiwei, Zhang, Yanmin, Chen, Yadong, Ji, Weiwei, Zhang, Hao, Cao, Huanhuan, Li, Xionghui, Gong, Rui, Wan, Yakun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013425/ https://www.ncbi.nlm.nih.gov/pubmed/33821254 http://dx.doi.org/10.1002/mco2.60

Ejemplares similares

Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma
por: Ma, Linlin, et al.
Publicado: (2022)

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
por: Xu, Caili, et al.
Publicado: (2023)

Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
por: Ma, Linlin, et al.
Publicado: (2020)

Structural basis of nanobodies neutralizing SARS-CoV-2 variants
por: Shi, Zhenzhong, et al.
Publicado: (2022)

Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice
por: Liu, Song, et al.
Publicado: (2022)

Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library
por: Yan, Junrong, et al.
Publicado: (2015)

Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
por: Stefan, Maxwell A., et al.
Publicado: (2021)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants
por: Yu, Bingchen, et al.
Publicado: (2022)

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
por: Dong, Jianbo, et al.
Publicado: (2020)

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
por: Güttler, Thomas, et al.
Publicado: (2021)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

Inhaled nanobodies against COVID-19
por: Martinez-Delgado, Gustavo
Publicado: (2020)

Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis
por: Liu, Rong, et al.
Publicado: (2023)

An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation
por: Schoof, Michael, et al.
Publicado: (2020)

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
por: Chen, Wei-Hung, et al.
Publicado: (2023)

Nanobody-based label-free photoelectrochemical immunoassay for highly sensitive detection of SARS-CoV-2 spike protein
por: Chen, Yun, et al.
Publicado: (2022)

Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications
por: Yan, Junrong, et al.
Publicado: (2014)

A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains
por: Yao, Hebang, et al.
Publicado: (2023)

Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
por: Dong, Jianbo, et al.
Publicado: (2021)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
por: Hanke, Leo, et al.
Publicado: (2022)

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2021)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
por: Yang, Jing, et al.
Publicado: (2022)

Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
por: Ma, Huan, et al.
Publicado: (2021)

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
por: Modhiran, Naphak, et al.
Publicado: (2023)

Identification of two novel neutralizing nanobodies against swine hepatitis E virus
por: Chen, Yiyang, et al.
Publicado: (2022)

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
por: Pymm, Phillip, et al.
Publicado: (2021)

Uniform Orientation of Biotinylated Nanobody as an Affinity Binder for Detection of Bacillus thuringiensis (Bt) Cry1Ac Toxin
por: Li, Min, et al.
Publicado: (2014)

Development of Thermally Stable Nanobodies for Detection and Neutralization of Staphylococcal Enterotoxin B
por: Hughes, Anna C., et al.
Publicado: (2023)

Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike Protein
por: Su, Qianling, et al.
Publicado: (2022)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
por: Zhao, Dongping, et al.
Publicado: (2022)

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics
por: Zhao, Shaojuan, et al.
Publicado: (2021)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

Camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2021)

Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells
por: Tang, Jinle, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d9803hpscjd2l3ap8sdtareejm